{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:52:39Z","timestamp":1787820759442,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) remains an important safety issue in surgery. Although enoxaparin is the most common medication for VTE chemoprophylaxis in plastic surgery, several limitations have been discussed that may contribute to breakthrough VTE events. These include the following: (1) the need for weight-based dosing; (2) the need for factor Xa monitoring to ensure adequate therapeutic levels; and (3) the need for subcutaneous injection. Apixaban may represent a potential solution; however, experience with direct factor Xa inhibitors in the plastic surgery literature is limited. Thus, the authors present a first-of-its-kind randomized controlled trial of apixaban versus enoxaparin for VTE chemoprophylaxis among high-risk breast cancer patients undergoing autologous breast reconstruction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a single-center, blinded, randomized controlled trial comparing enoxaparin versus apixaban VTE chemoprophylaxis among women undergoing microsurgical breast reconstruction with free abdominal flaps.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Seventy-nine eligible patients were enrolled, of whom 40 (51%) were randomized to enoxaparin and 39 (49%) were randomized to apixaban. Treatment groups demonstrated similar demographics and comorbidities. Overall, of bleeding events that occurred after initiation of VTE chemoprophylaxis, 1 (3%) occurred in the apixaban arm and 1 (3%) occurred in the enoxaparin arm. On multivariable logistic regression adjusting for demographic\/clinical characteristics, the adjusted odds of a bleeding event for apixaban versus enoxaparin was 1.0 (99% CI, 0.9 to 1.1). There were no symptomatic VTE events reported in either treatment arm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Apixaban is a safe fixed-dose, oral VTE chemoprophylaxis agent for use after autologous breast reconstruction. It presents a novel paradigm shift in VTE prevention after reconstructive surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL QUESTION\/LEVEL OF EVIDENCE:<\/jats:title>\n                    <jats:p>Therapeutic, II.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/prs.0000000000012168","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T16:03:59Z","timestamp":1746547439000},"page":"809-815","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Venous Thromboembolism Chemoprophylaxis in Plastic Surgery: A Randomized Controlled Trial of Apixaban versus Enoxaparin"],"prefix":"10.1097","volume":"156","author":[{"given":"Arash","family":"Momeni","sequence":"first","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja S.","family":"Yesantharao","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Meyer","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Posternak","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Shefren","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Przybylo","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Januszyk","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Pannucci","sequence":"additional","affiliation":[{"name":"Plastic Surgery Northwest."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"R1-20260202","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4048\/jbc.2006.9.4.354","article-title":"Pulmonary thromboembolism following mastectomy with immediate TRAM in the patients with breast cancer: a prospective study.","volume":"9","author":"Lee","year":"2006","journal-title":"J Breast Cancer"},{"key":"R2-20260202","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/SAP.0000000000001249","article-title":"Venous thromboembolism after surgical treatment of breast cancer.","volume":"80","author":"Momeni","year":"2018","journal-title":"Ann Plast Surg"},{"key":"R3-20260202","doi-asserted-by":"crossref","first-page":"168e","DOI":"10.1097\/PRS.0b013e318254b4ee","article-title":"Evidence-based practices for thromboembolism prevention.","volume":"130","author":"Murphy","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"R4-20260202","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2010.08.018","article-title":"Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients.","volume":"212","author":"Pannucci","year":"2011","journal-title":"J Am Coll Surg"},{"key":"R5-20260202","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/PRS.0b013e31822b6817","article-title":"Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients.","volume":"128","author":"Pannucci","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"R6-20260202","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.","volume":"375","author":"Lassen","year":"2010","journal-title":"Lancet"},{"key":"R7-20260202","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","article-title":"Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.","volume":"363","author":"Lassen","year":"2010","journal-title":"N Engl J Med"},{"key":"R8-20260202","doi-asserted-by":"crossref","first-page":"1144e","DOI":"10.1097\/PRS.0000000000005613","article-title":"Breast reconstruction with free abdominal flaps is associated with persistent lower extremity venous stasis.","volume":"143","author":"Momeni","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R9-20260202","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0036-1594297","article-title":"Increased lower extremity venous stasis may contribute to deep venous thrombosis formation after microsurgical breast reconstruction\u2014an ultrasonographic study.","volume":"33","author":"Momeni","year":"2016","journal-title":"J Reconstr Microsurg"},{"key":"R10-20260202","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000002126","article-title":"Individualized venous thromboembolism risk stratification using the 2005 CAPRINI score to identify the benefits and harms of chemoprophylaxis in surgical patients.","volume":"265","author":"Pannucci","year":"2017","journal-title":"Ann Surg"},{"key":"R11-20260202","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/PRS.0000000000007780","article-title":"Optimal dosing of prophylactic enoxaparin after surgical procedures: results of the double-blind, randomized, controlled fixed or variable enoxaparin (FIVE) trial.","volume":"147","author":"Pannucci","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"R12-20260202","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/PRS.0000000000003159","article-title":"Inadequate enoxaparin dosing predicts 90-day venous thromboembolism risk among plastic surgery inpatients: an examination of enoxaparin pharmacodynamics.","volume":"139","author":"Pannucci","year":"2017","journal-title":"Plast Reconstr Surg"},{"key":"R13-20260202","doi-asserted-by":"crossref","first-page":"851e","DOI":"10.1097\/PRS.0b013e31826d9fc0","article-title":"How safe is thromboprophylaxis in abdominoplasty?","volume":"130","author":"Dini","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"R14-20260202","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/asj\/sjv243","article-title":"Safety and efficacy of novel oral anticoagulants vs low molecular weight heparin for thromboprophylaxis in large-volume liposuction and body contouring procedures.","volume":"36","author":"Morales","year":"2016","journal-title":"Aesthet Surg J"},{"key":"R15-20260202","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bjps.2016.02.011","article-title":"Novel oral anticoagulants in plastic surgery.","volume":"69","author":"Munson","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R16-20260202","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/blood-2023-184457","article-title":"A comparison of bleeding events among patients on apixaban, rivaroxaban, and warfarin for atrial fibrillation and\/or venous thromboembolism.","volume":"142","author":"Schaefer","year":"2023","journal-title":"Blood"},{"key":"R17-20260202","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/asj\/sjaa177","article-title":"Safety of rivaroxaban for postoperative venous thromboembolism prophylaxis following abdominal body contouring surgery: 600 patients.","volume":"41","author":"Vasilakis","year":"2020","journal-title":"Aesthet Surg J"},{"key":"R18-20260202","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1097\/GOX.0000000000000660","article-title":"Caprini scores, risk stratification, and rivaroxaban in plastic surgery: time to reconsider our strategy.","volume":"4","author":"Swanson","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"R19-20260202","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/PRS.0b013e318236215c","article-title":"The effect of postoperative enoxaparin on risk for reoperative hematoma.","volume":"129","author":"Pannucci","year":"2012","journal-title":"Plast Reconstr Surg"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000012168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T17:00:16Z","timestamp":1770051616000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000012168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000012168","relation":{},"ISSN":["0032-1052","1529-4242"],"issn-type":[{"value":"0032-1052","type":"print"},{"value":"1529-4242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}